Critical Analysis: Keryx Biopharmaceuticals (KERX) vs. Its Peers


Keryx Biopharmaceuticals is one of 288 public companies in the "Bio Therapeutic Drugs" industry, but how does it weigh in compared to its rivals? We will compare Keryx Biopharmaceuticals to related companies based on the strength of its risk, analyst recommendations, earnings, profitability, institutional ownership, dividends and valuation. Keryx Biopharmaceuticals' rivals have higher revenue and earnings than Keryx Biopharmaceuticals.



from Biotech News